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ABSTRACT Soluble oligomers of the amyloid b-protein (Ab) are linked to Alzheimer’s disease. Irrespective of the nature of the
nucleus before ﬁbril growth, dimers are essential species in Ab assembly, but their transient character has precluded, thus far,
high-resolution structure determination. We have investigated the effects of the point mutation A21G on Ab dimers by performing
high temperature all-atom molecular dynamics simulations of Ab40, Ab42, and their Flemish variants (A21G) starting from their
ﬁbrillar conformations. Ab dimers are found in equilibrium between various topologies, and the absence of common structural
features shared by the four species makes problematic the design of a unique inhibitor for blocking dimers. We also show that the
impact of the point mutation A21G onAb structure and dynamics varies fromAb40 to Ab42. Finally, we provide a possible structural
explanation for the reduced aggregation rate of Ab ﬁbrils containing the Flemish disease-causing mutation.
INTRODUCTION
The formation of amyloid ﬁbrils is a hallmark of many
human diseases and results from the misfolding of proteins
into cross b-sheet structure (1). Alzheimer’s disease, for
instance, is characterized by deposition of amyloid ﬁbrils
in the brain parenchyma and cortical blood vessels. This
accumulation consists of 40- and 42-mer peptides (Ab40 and
Ab42) produced through endoproteolysis of the b-amyloid
precursor transmembrane protein by b- and g-protease (2).
Thus far, a high-resolution structure for Ab40 and Ab42 is not
available, in contrast to a seven-residue peptide fragment
from yeast protein Sup35 (3), but we know that the b-strands
run perpendicular to the ﬁber axis, the hydrogen-bonding
interactions run parallel to the ﬁber axis, and the chains are in
parallel register. Several models have been proposed, based
on solid-state NMR experiments (4,5), hydrogen/deuterium
(H/D) exchanges measurements with (6) or without muta-
genesis data (7), and proline scanning methods (8,9). All
models share a disordered N-terminal region spanning at
least residues 1–10, and differ in the number and length of
strands and loops, and in the network of intermolecular
hydrogen-bonding and sidechain-sidechain interactions.
The kinetic model, by which the Ab peptides aggregate
into amyloid ﬁbrils, is believed to follow a nucleation-
growth model, with a lag-phase of several days. Oligomer-
ization is very sensitive to amino-acid variations. Residues
41 and 42 affect the characteristics of the nucleus (10); Ab42
forms ﬁbrils at a higher rate than Ab40 and the Alzheimer’s
disease-causing A21G (Flemish) mutation (11) has a slower
aggregation kinetic than wild-type Ab and the E22Q (Dutch)
(12,13), E22K (Italian) (14), E22G (Arctic) (15), and D23N
(Iowa) (16) mutations (17,18).
In contrast to the late aggregates or protoﬁbrils which are
well characterized, the structures of the oligomers forming in
the early steps of aggregation are poorly understood because
they are transient in character. Although dimers are in
equilibrium with higher-order species before the formation
of the nucleus, dimer formation is certainly critical in Ab
assembly. However, much remains to be elucidated regard-
ing the structure of these dimers, which are sufﬁcient for
toxicity (19,20), from both the experimental and theoretical
fronts. We know, however, that Ab40 and Ab42 form stable
dimers in solution using ﬂuorescence resonance energy trans-
fer (21–23). The stability of several Ab species in dimers and
higher-order mers has been investigated by explicit solvent
molecular dynamics (MD) simulations, including dimers of
Ab10–35 (24), hexamers of Ab15–36 (25,26), and octamers of
Ab9–40 (27). These studies at 300 K, however, explore local
ﬂuctuations around preformed arrangements. The assembly
process of Ab1–40 and Ab1–42 dimers was studied by dis-
continuous MD (DMD) simulations, and planar b-strand Ab
dimers were found instable (28). Similarly, the aggrega-
tion process of multimers of Ab40 and Ab42 (29) has been
explored using DMD simulations, but the results remain to
be conﬁrmed using a more elaborated chain representation
and force ﬁeld (29).
In this study, we have investigated the effects of the point
mutation A21G on Ab dimers by performing all-atom
molecular dynamics simulations of Ab9–40, Ab9–42 and their
Flemish variants (A21G) at 400 K starting from their ﬁbrillar
conformations. Note that omission of residues 1–8 does not
prevent the peptide from forming ﬁbrils (30). The point
mutation A21G is interesting because no mechanistic expla-
nation has been offered for its effect on aggregation rate, in
contrast to the mutations at positions 22 and 23 (31,32). We
emphasize that our goal is not to determine the equilibrium
structures of Ab dimers. This is currently out of reach by
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using high temperature MD simulations or replica exchange
simulations with current computer facilities. Rather, our aim
is to understand at an atomic level of detail the effects of the
mutation A21G on ﬁbrillarlike dimeric structures of Ab40
and Ab42.
MATERIALS AND METHODS
Differences in Ab40 and Ab42 ﬁbril models
The Ab42 sequence is
DAEFRHDSGYEVHHQKLVFFA
EDVGSNKGAIIGLMVGGVVIA
with the amino acids 21 underlined and 41 and 42 in bold. Several ﬁbril
models have been proposed. Both Ab40 models of 2002 (4) and 2006 (5)
models of Petkova et al. are based on solid-state NMR measurements, but
the 2006 model includes measurements that provide direct constraints on
quaternary structure. The 2005 Ab42 model of Luhrs et al. (6) is based on the
solid-state NMR measurements carried by Petkova et al. in 2002, and on
their own H/D exchange and mutagenesis data. Olofsson et al. (7) have also
performed H/D exchange measurements on Ab42 ﬁbrils. All these models
show a cross-b structure with parallel b-sheets, but signiﬁcant differences
are identiﬁed.
1. Residues 1–8 are disordered in the 2002 and 2006 Ab40 models, versus
residues 1–15 in the 2005 Ab42 model proposed by Luhrs et al. (6). As
the result, b-strand S1 encompasses residues 12–24 in the Ab40 models
versus 18–26 in the Ab42 Luhr’s model, and b-strand S2 covers resi-
dues 30–40 and 31-42, respectively. In contrast, Olofsson et al. (7)
found that residues 11–24 are highly protected in Ab42, in agreement
with the Petkova’s Ab40 models, so the two ﬁbril structures may
actually be very similar.
2. The salt bridge between residues Asp23 and Lys28 and the side-chain
interactions are intramolecular in the 2002 Ab40 model, but intermolec-
ular in the 2005 Ab42 model. The inter-b-sheet side-chain interactions are
between the odd-numbered residues of S1 and S2 in the 2002 Ab40
model, and between the odd-numbered residues of S1 and the even-
numbered residues of S2 in the 2005 Ab42 model. However, the revisited
2006 Ab40 model indicates intermolecular Asp
23–Lys28 salt bridges and
contacts between odd residues in S1 with even residues in S2.
These analyses, with the proposed model of Williams et al. (8), indi-
cate that the ﬁbril structures are likely to evolve as additional experimental
data become available, but such a reﬁnement is very complicated since the
dimensions and morphologies of ﬁbrils vary with solution conditions and
degrees of agitation (33).
Dynamics simulations
MD simulations are performed at neutral pH using the program
GROMACS2.0 and the all-hydrogen energy function GROMOS96 (34).
The starting point is the 2002 NMR solid-state structure of Ab40 ﬁbril (4),
which lacks the atomic positions of residues 1–8. Note that both the Ab42
model and the 2006 Ab40 model were unknown at the beginning of this
work. The initial structures for Ab42 and the A21G variants are constructed
using the SWISS-MODEL server (35).
All Abmodels are solvated in a rectangular box of 90, 50, and 40 A˚ sides
with ;6000 simple point-charge water molecules and simulated using
periodic boundary conditions. The particle-mesh Ewald method is used with
a cutoff distance of 12 A˚. Abmodels are minimized by 300 steps of steepest
descent and 600 steps of conjugate gradient and then equilibrated at the
desired temperature for 80 ps under Ca atom restraints followed by 80 ps
free of any atomic restraints. Subsequently, MD simulations are performed
in the canonical NPT ensemble. The time step for dynamics is 2.0 fs using
the LINCS algorithm and the list of nonbonded interactions is updated every
20 fs. Temperature is controlled using a weak coupling to a bath of constant
T (coupling time of 0.1 ps) and pressure by a weak coupling to a bath of
constant P (1 atm, coupling time of 0.5 ps).
All Ab models are simulated for 10 ns at 400 K to increase phase space
sampling. This is an advisable choice in contrast to the standard tempera-
ture (500 K) to induce unfolding and conformational changes. The Van
Gunsteren group (36) showed that the use of temperatures higher than 400 K
is very likely to affect the unfolding, kinetics, and thermodynamics of
proteins. Dinner and Karplus (37) studied thermal folding and unfolding of
lattice proteins and found that unfolding is the reversal of fast-track folding.
Klimov and Thirumalai (38) moved one step further and showed that folding
pathways at 300 K and unfolding pathways at 390–420 K are similar using
off-lattice models. It follows that the present paths at 400 K are closely
related to the conformational changes at 300 K, although the population of
each dominant unfolded state changes with T. The Ab40 and its A21G
variant are also simulated starting from the same structure using different ini-
tial velocities. All runs took 80 days on a cluster of ﬁve 1.5-GHz processors.
The trajectories are analyzed using several order parameters. These
include the Ca root mean-square (RMS) deviations from the minimized
NMR structure and the Ca RMS ﬂuctuations (RMSF) relative to the average
MD structure. We also follow the evolution of the radius of gyration Rg, the
end-to-end distance, and the percentage of secondary structure content using
the STRIDE program (39). Because the Ab models differ in length, we only
use residues 9–40 to compare the trajectories. The MD-generated structures
are also clustered using a Ca RMS deviation cutoff of 3 A˚, and analyzed by
their contact maps and percentages of native contacts. Here, native refers to
the 2002 Ab40 solid-state NMR conformation, and a contact is deﬁned when
aliphatic carbon atoms of two nonsequential side chains come within 5.4 A˚
or any other atom of two nonsequential side chains lies within 4.6 A˚ (40).
The structural models are drawn by using the VMD software (41).
RESULTS
Conformational stability of dimers
The distributions of the Ca RMS deviations (RMSDs) of
residues 9–40 from the minimized structures of monomers A
and B are displayed in Fig. 1, a and b, for all Ab models.
Ab40 is much less ﬂexible than Ab42 and the mutants. The
Ca RMSD population of monomer A is essentially centered
at 0.5 nm in Ab40, and varies between 0.5 and 0.9 nm in
Ab42-A21G, 0.7 and 1.1 nm in Ab42, and between 0.7 and
1.25 nm in Ab40-A21G. The variability in conformations can
be further explored by the distributions of the end-to-end Ca
distances between residues 9 and 40 in Fig. 1, c and d. In
Ab40, the most populated end-to-end distance is centered at
2 nm in monomer A and spans larger distances in monomer
B, which is in contrast with Ab42, where the end-to-end
distance ﬂuctuates between 0.8 and 2.8 nm in both mono-
mers. Higher stability of Ab40 is also seen in the evolution of
the radius of gyration (Rg) with time in Fig. 1 e and the
distributions of Rg in Fig. 1 f. In Ab40, the MD-averaged Rg
is 1.5 nm to be compared to the NMR value of 1.75 nm, and
the Rg distribution has a well-deﬁned peak. This contrasts
with Ab42 and the mutants which have a lower mean radius
of gyration (1.1 nm in Ab40-A21G, Fig. 1 e) and larger
standard deviations of Rg (Fig. 1 f).
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FIGURE 1 Dynamical properties as a function
of Ab species. Distributions of the RMSDs from
the minimized structures: (A) monomer A and (B)
monomer B. Distributions of the Ca–Ca distances
between residues 9 and 40: (C) monomer A and (D)
monomer B. Radius of gyration as a function of
time (E) and distributions of the radius of gyration
(F); both panels use the dimer of each species.
RMSFs from their mean structures: (G) monomer
A and (H) monomer B. Distributions of the solvent-
exposed surface area: (I) main-chain atoms of
residues 9–40 and (J) side-chain atoms of residues
9–40; both panels use the dimer of each species.
Four colors are used to distinguish the species:
green (Ab40); blue (Ab40-A21G); black (Ab42);
and red (Ab42-A21G).
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The RMSFs, with respect to the average MD structure in
Fig. 1, g and h, show high ﬂexibility at the N-terminal and
C-terminal extremities for all models, in agreement with
MD studies of a dimer of Ab10–35 (24) and eight Ab40
peptides (27). The largest differences in RMSF between
all Ab species are found in the loop between S1 and S2
(residues 21–30, RMSF of 0.3 A˚ in Ab40 versus 0.6 A˚ in
other species, Fig. 1 g), and in strand S2 (notably for
monomer B, Fig. 1 h). These regions match the locations
where experimental data show the lowest structural deter-
mination.
The structural ﬂuctuations, using the RMSD from themini-
mized and MD-averaged structures, the end-to-end distance,
and the radius of gyration show that monomer A is less
ﬂexible than monomer B. This asymmetry in structural ﬂuc-
tuations of the monomers in a homodimer has been discussed
in 10-ns MD simulations on decoys of Ab10–35 at 300 K
(24). Asymmetric conformational changes were also ob-
served by lattice (42) and off-lattice (43) aggregation MC
simulations of homodimer amyloid-forming models. The
effect of this asymmetry on ﬁbril nucleus formation, remains,
however, to be determined.
Overall, we see that the ﬂexibility increases in the fol-
lowing order: Ab40 / Ab42 A21G / Ab42 and Ab40-
A21G. This conclusion is also supported by the analysis of
the solvent-exposed surface area, using the method of Lee
and Richards (44), although the role of water molecules on
dimer unfolding changes according to different sequences.
The backbone atoms of residues 9–40 are more exposed to
the solvent in Ab42 and Ab40-A21G than in Ab40 (Fig. 1 i).
The side-chain atoms of residues 9–40 are more exposed in
Ab40 than in Ab42 and the Ab variants (Fig. 1 j). (Identical
results are obtained excluding residue 21.) This change in
solvent accessibility does not have a one-to-one mapping
with the amino-acid number. For instance, the distributions
of solvent accessibility of the Asp22 side chain match exactly
in all simulations, whereas those of Asp11 side-chain change
(data not shown).
To investigate whether these results vary with different
initial velocity distributions, the simulations of Ab40 and
Ab40-A21G are repeated for 10 ns using the same starting
structure. The RMSD between all pairs of structures is
determined using a pool of 1000 structures taken at 10-ps
intervals. By calculating for each Ab species the number of
pairs of structures as a function of the RMSD deviation, we
see that the RMSD plots superpose well from one run to
another for Ab40 (Fig. 2 a) and Ab40-A21G (Fig. 2 b).
Consistency between the runs is also seen in the Ca RMSD
from the minimized structure in Fig. 2 c and the evolution of
the radius of gyration with time in Fig. 2 d. Fig. 2, e and f,
show the RMSF proﬁles of monomers A and B in Ab40-
A21G. The RMSFs are very similar in monomer A, but differ
by 2 A˚ in the 25–32 region of monomer B. Overall, these
analyses indicate that different simulations on the same
sequence produce equivalent results.
Effects on secondary structures and
loop conformations
Table 1 gives the mean percentage and standard deviation of
a-helix, b-strand, and turn and random coil contents, using
residues 9–40 for all species. As expected from high tem-
perature simulations ignoring interactions with neighboring
protoﬁlaments, the percentage of b-strand decreases, but the
variation with Ab length and mutation A21G is rather sur-
prising. Note that the percentage of b-strand is 83% (26:31)
in the NMR-model of Ab9–40. The MD-averaged percentage
of b-strand is 46% in both Ab40 and Ab42-A21G, and 37%
in Ab40-A21G and Ab42. The variation in b-strand content
does not result from an increase in a-helix (its population
amounts to a few percent) and turn content, but in random
coil conformations.
To quantify the effects of extending or mutating Ab40 on
secondary structures, we calculate the probability of each
residue to be assigned with b-strand character along the
trajectories. We see that, in Ab40, the strands S1 and S2 are
rather well-conserved spanning residues 11–20 and 30–36 in
both monomers (Fig. 3 a), whereas in Ab42 and the mutants,
monomer B is clearly less b-prone than monomer A, and the
details vary from one Ab species to another. For instance, the
reduction of b-content in Ab40-A21G results from a shorter
strand S1 in monomer B spanning residues 12–18 (but not
monomer A, Fig. 3 b), and shorter strands S2 in monomers A
and B. In contrast, the reduction of b content in Ab42 comes
from a shorter strand S2 in monomer A and broken strands
S2 in monomer B (see the minimum at positions 37–38 in
Fig. 3 c). Finally, the combined impact of A21G and residues
41–42 on b-strand percentage is rather complex: they
shorten strand S1 (monomer B) or extend it by four residues
(monomer A); they break strand S2 with turn preferences at
positions 37–38 (monomer B) or extend it at positions 39–41
(Fig. 3 d).
To determine why the mutation A21G destabilizes
b-sheets in Ab40 but not in Ab42, in Fig. 4 we plot the
Ramachandran plot of the residue 21 from all MD-generated
structures of each Ab model. We see that in Ab40 and Ab42,
Ala21 explores essentially the favored (f,c) regions with a
high density of residues with b-character (Fig. 4, a and c).
On the other hand, in Ab40-A21G, the Ramachandran plot of
Gly21 has a typical pattern of a glycine (Fig. 4 b), whereas in
Ab42-A21G, the Ramachandran plot resembles that of a
standard residue (Fig. 4 d). These results indicate that the
residues 41 and 42 have a strong impact on the ﬂexibility of
the residue Gly at position 21, and may affect the loop-
spanning residues 21–30.
To quantify the variations of this loop, we calculate the
intramolecular and intermolecular distances between the Nz
atom of Lys28 and Cg atom of Glu22 and Asp23. Salt bridges
are considered formed if they come within 4.2 A˚ (45). The
formation times of all salt-bridges during the trajectories are
reported in Table 2. As expected, we ﬁnd that the native
3832 Huet and Derreumaux
Biophysical Journal 91(10) 3829–3840
intramolecular Asp23-Lys28 salt bridge is populated in all
models, although to a lesser extent in Ab42 (34% of the time)
compared to Ab40 (52% of the time). Note that A21G
reduces the occurrence of this salt bridge: 32% of the time in
Ab40-A21G and 22% of the time in Ab42-A21G. Similarly,
the nonnative intramolecular Glu22-Lys28 salt bridge is also
populated in all models: 10.7%, 9.7%, 14.8%, and 15.8% for
Ab40, Ab42, Ab40-A21G, and Ab42-A21G, respectively.
The ﬁnding of two distinct Coulombic interactions involving
Lys28 are fully consistent with recent NMR experiments of
the monomer of the fragment Ab21–30 (31). Interestingly, the
intermolecular salt bridge between Asp23 of monomer B and
Lys28 of monomer A, one ﬁngerprint of the 2005 Ab42
model and the 2006 Ab40 model, is also populated in all
simulations, and notably in Ab40 (22.6% of the time) and
Ab42-A21G (13.4% of the time).
Geometrical characteristics of ﬁnal Ab dimers
The centers of the most populated clusters within 7.5–10 ns
are shown in Fig. 5. The populations of these clusters vary
from 40% (Ab40-A21G) to 80% (Ab42-A21G). The side-
chain-sidechain contact map of each ﬁnal topology is given
in Fig. 6.
As a result of unfolding, the percentage of native
sidechain-sidechain contacts averages 40% in Ab40, 22%
in Ab42, 20% in Ab42-A21G, and 19% in Ab40-A21G, and
all ﬁnal structures adopt nonnative topologies, as described
TABLE 1 Secondary structure compositions of Ab40, Ab42
and their A21G variants from explicit solvent MD simulations
at 400 K
Protein Strand Helix Turn Coil
Ab40 46.4 6 9.8 0.3 6 1.6 2.2 6 2.7 51.0 6 11.3
Ab40-A21G 37.0 6 14.6 0.6 6 3.1 7.2 6 5.8 55.2 6 12.1
Ab42 37.1 6 12.5 0.6 6 2.3 4.2 6 4.0 58.1 6 13.5
Ab42-A21G 47.2 6 11.4 0.6 6 2.8 3.8 6 3.7 48.3 6 13.2
Secondary structure assignment is carried out using the STRIDE program
(39). For each protein, we give the mean and standard deviation of secondary
structure percentages using only residues 9–40.
FIGURE 2 Effects of two different
initial velocities on Ab40 and Ab40-
A21G properties. Number of pairs of
structures as a function of the RMSD
for Ab40 runs (A) and Ab40-A21G runs
(B). RMSD (C) and radius of gyration
(D) as a function of time for the dimers
of Ab40-A21G. RMSFs from their
mean structures for the monomer A
(E) and the monomer B (F) of Ab40-
A21G. Solid lines are used for the ﬁrst
seed and dotted lines for the second
seed.
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by TOPS cartoons (46). In what follows, we analyze, for
each Ab species, the topological reorganization, the salt
bridge within the (21–30) loop, and the intra- and intermo-
lecular interactions involving notably Met35, Phe19, Phe20,
Ile41, and Ala42 (5). We recall that, in the starting Ab40 struc-
ture shown in Fig. 5 a, residues i of monomer A are in contact
with residues i of monomer B, both intramolecular and inter-
molecular contacts are formed between Phe19 and Met35, and
between His13 and Ile41 (Fig. 6 a, panel AB).
The ﬁnal topology of Ab40 in Fig. 5 b is a planar four-
stranded b-sheet with native parallel registers between the
strands S1 and between the strands S2, and nonnative
antiparallel hydrogen-bonds between S2 of monomer B and
S1 of monomer A. S1 encompasses residues 11–20 in both
monomers, S2 spans residues 31–38 in monomer A and
residues 31–35 in monomer B. This structure, which lacks
the salt bridge between Asp23 and Lys28, has replaced the
native intramolecular contacts between the strands S1 and S2
(Fig. 6 b, panels AA and BB) by nonnative intermolecular
contacts between residues 34–40 of monomer A and residues
14–20 of monomer B (Fig. 6 b, panel BA).
Ab40-A21G in Fig. 5 c is also a four-stranded b-sheet with
the strands S1 in parallel register, but the strands S2 are
separated by 15 A˚ from each other and folded back against
their strands S1. Strand S1 spans residues 13–19 and 13–16
in monomers A and B, whereas strand S2 covers residues
35–38 in monomer A and 34–35 in monomer B. The
interface between the chains is essentially nonnative (Fig. 6
c, panels AB and BA), although the intramolecular intermo-
lecular Phe19 and Met35 is preserved, and is characterized by
a cluster of interactions between Met35, and eight residues at
positions 17, 19, 20, 23, 27, 28, and 31 (Fig. 6 c, panel AA).
The ﬁnal topology of Ab changes drastically with the
presence of residues Ile41 and Ala42. Ab42 is essentially
characterized by a seven-stranded b-sheet, although a short
a-helix occurs at positions 22–26 in monomer A (Fig. 5 d).
The strands cover residues 14–20, 26–27, 30–31, and 36–41
in monomer A and residues 10–20, 32–33, and 38–40 in
monomer B. Two salt bridges are formed: one between
Glu22 and Lys16 within monomer B and the other between
Asp23 of monomer B and Lys28 of monomer A. Met35 of
monomer A is in contactwithPhe19of bothmonomers. In con-
trast to Ab42, Ab42-A21G leads to a ﬁve-stranded b-sheet
with mixed parallel and antiparallel strands (Fig. 5 e). Strands
encompass residues 11–27 and 29–39 inmonomer A, and res-
idues 13–18, 25–33, and 39–42 in monomer B. The intra-
molecular salt bridge between Glu22 and Lys28 is only formed
in monomer B, and Met35 is in contact with Phe19 and Phe20
of monomer A.
It is of interest to determine the native interactions and the
structural features that are shared by all four Ab species. We
ﬁnd that only the native intermolecular contact between
FIGURE 3 MD-averaged probability
ofb-strand occurrence along the amino-
acid sequence. Ab40 (A), Ab40-A21G
(B), Ab42 (C), and Ab42-A21G (D).
The location of the b-strands S1 and S2
within the 2002 Ab9–40 model and the
2005 Ab17–42 model are indicated by
thick and thin solid lines, respectively.
In each panel, solid lines are used for
the monomer A and dotted lines for the
monomer B.
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His14 residues is conserved in all species. All ﬁnal Ab dimers
disrupt the interfaces between the strands S1 and S2, and
between the strands of S2, but tend to preserve the inter-
actions between the central hydrophobic clusters (CHC)
spanning residues Leu17-Ala21, although the contacts ob-
served are not conserved. For instance, the native intermo-
lecular interaction between Phe19 residues is conserved in
Ab40, Ab42, and its variant, but not in Ab40-A21G.
Comparison with in vitro and previous in
silico experiments
Solution NMR studies of Ab10–35 (47), Ab1–40, and Ab1–42
(48) showed that CHC is the most structured region.
Similarly, MD simulations of Ab10–35 in monomeric (49)
and dimeric (24) forms showed that the CHC region is much
less ﬂexible than the rest of the protein. We ﬁnd that this
region, which is known to be essential for aggregation (50),
is well conserved in wild-type Ab40 and Ab42, but not in their
variants, strands S1 covering residues 13–16 and 13–18 in the
monomers B of Ab40-A21G and Ab42-A21G, respectively.
The residues Ile41 and Ala42 are known to play a crucial
role in Ab oligomerization. Moritomo et al. (9) found that
the Ab42 I41T and A42T mutants aggregate potently, and
proposed that the hydrophobicity of the C-terminal two resi-
dues of Ab42 is not related to its aggregative ability, and that
the C-terminal three residues adopt the b-sheet.
Hou et al. (48) measured 1Ha,
13Ca, and
13Cb chemical
shift indices of the Ab1–40 and Ab1–42 monomeric species
and found that the C-terminus of Ab1–42 has a propensity for
b-sheet structure, whereas that of Ab1–40 has not. Lazo et al.
(31) coupled limited proteolysis and mass spectrometry and
found that the residues Val39-Ala42 are protease-resistant in
Ab1–42, while the residues Val
39-Ala40 are not in Ab1–40. We
ﬁnd that the residues 41 and 42 have two major effects on the
structure. Firstly, they favor the extension and formation of
FIGURE 4 Ramachandran plot of residue 21. (A) Ab40,
(B) Ab40-A21G, (C) Ab42, and (D) Ab42-A21G. Dihedral
angles f and c are reported using both monomers.
TABLE 2 Formation time percentage of intramolecular and
intermolecular salt bridges between the residues Glu22 and
Lys28 and between the residues Asp23 and Lys28
NMRy
Interaction* Ab40 Ab42 Ab40 Ab40-A21G Ab42 Ab42-A21G
22A-28A 0 0 1.1 7.5 9.0 0
22A-28B 0 0 0 2.0 0 0
22B-28B 0 0 9.6 5.3 0 12.2
22B-28A 0 0 0 0 0.7 3.6
23A-28A 100 0 28.5 18.5 21.6 7.4
23A-28B 0 0 0 0.9 0 0.7
23B-28B 100 0 23.3 13.8 12.1 15.1
23B-28A 0 100 22.6 3.3 2.1 13.4
*Time percentage of formed salt bridge xxX-yyY during the 10-ns
simulations. In this notation, xx and yy refer to the amino-acid number
and X and Y to the monomer number. Salt bridges are considered formed if
the chosen atoms (described in the text) come within 4.2 A˚.
yRefers to the 2002 Ab40 model (4) and the 2005 Ab42 model (6).
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b-strand at position 39–42. Secondly, they disrupt the native
interface between the chains and enhance the number of
intramolecular interactions, irrespective of the amino acid at
position 21. As seen in panels AA and BB of Fig. 6, d and e,
both Ab42 and Ab42-A21G species display two new
domains (encircled) that are absent in the Ab40 species:
one involving residues 13–27 and 29–42 in monomer A, the
other involving residues 10–17 and 37–42 in monomer B. In
particular, Ab42 and its mutant display de novo intramolec-
ular interactions between (Ile41, Ala42) and (His14, Gln15,
Lys16, Val18, and Phe19). In addition, we see that Met35
contacts Val40 in Ab42 and its A21G mutant, whereas Met
35
does not contact the C-terminal residues in Ab40 and its
A21G mutant. This difference in Met35 contacts between the
FIGURE 5 Final structures and topologies
of Ab dimers. (A) The initial dimer of Ab40
used for the simulations, and the location of the
residues His14, Phe19, Glu22, Asp23, Lys28, and
Met35. The center of the most populated
clusters within 7.5–10 ns are shown for Ab40
(B), Ab40-A21G (C), Ab42 (D), and Ab42-
A21G (E). The TOPS cartoon of each topology
is also given and full explanation of the cartoons
can be found at http://www3.ebi.ac.uk/tops/
ExplainSummary.html. In brief, monomer A
runs from NA to CA, and monomer B from NB
and CB. Triangular and circular symbols rep-
resent theb-strands anda-helices, respectively.
Triangles on the same horizontal row indicate
hydrogen-bonding interactions between the
strands. In all panels, residues 9–25 are in
blue within monomer A and in red within
monomer B; residues 26–30 are in white, and
residues 31–40 (or 31–42) are in gray within
monomer A and in orange within monomer B.
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Ab40 and Ab42 species is made possible by the formation of
a turn centered at Gly37-Gly38 in Ab42, but not in Ab40 (see
Fig. 3). Such a ﬁnding is fully consistent with DMD
simulations of multimers (29) and MD simulations of a
monomer (51).
Several studies have emphasized the importance of the
intramolecular salt bridge between residues 23 and 28 in
ﬁbril formation (5,33). An engineered lactam bridge between
Asp23 and Lys28 increases the Ab1–40 ﬁbrillogenesis rate by
three orders of magnitude (52). Solution NMR study and
DMD simulations of the fragment Ab21–30 also suggested a
possible mechanism for the effects of mutations at positions
22 and 23, based on a change of the populations of the salt
bridges 23:28 and 22:28 (31,32). In contrast, the NMR ﬁbril
model of Ab17–42 points to an intermolecular salt bridge
between residues 23 and 28. Our simulations provide strong
FIGURE 6 Sidechain-sidechain contact
maps of Ab dimers. (A) Initial Ab40, (B)
ﬁnal Ab40, (C) ﬁnal Ab40-A21G, (D) ﬁnal
Ab42, and (E) ﬁnal Ab42-A21G maps for
the structures shown in Fig. 5. Each Ab
species is described by four panels: panels
AA andBB show the intramolecular contacts
within monomers A and B, respectively;
panels AB and BA show the intermolecular
interactions between monomers A and B,
and between B and A, respectively. A diag-
onal dotted line is drawn to separate the
native (upper) from nonnative (lower) in-
teractions, and a vertical and horizontal
dotted line indicates the position of the
residue Met35. The criteria used for deﬁning
a contact are described in Materials and
Methods.
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evidence of the existence of all these salt bridges in equi-
librium, whose populations are determined by the presence of
Ile41 and Ala42, and the nature of the amino acid at position 21.
CONCLUSIONS
We have studied the impact of the point mutation A21G on
the structure of Ab dimers, by using a total of six unfolding
molecular dynamics simulations at 400 K. All simulations of
Ab40, Ab42, and their variants start from the conformation
within the NMR 2002 ﬁbril model of Ab40. Although this
structure differs from the 2005 and 2006 models, it is a
reasonable starting point because there is strong evidence
that a unique structure does not exist, polymorphism likely
reﬂecting multiples alternatives for the packing and interac-
tions within the core of the ﬁbril (33). In addition, we are
only interested in the qualitative effect of Flemish mutation
on the stability of different Ab dimers and on the kinetics of
assembly. Quantitative analysis is beyond the scope of this
work for two reasons. The ﬁrst reason is that a direct com-
parison between conformational distributions from experi-
ment and simulation is difﬁcult. Circular dichroism and NMR
studies of low molecular weight Ab, consisting of monomers
and dimers in equilibrium with multimers as large as hept-
amers, give 60–80% of random coils, 10–20% of b-strand,
and,10% of a-helix (53–55). We obtain a time-averaged b-
percentage of 26% (Ab42,Ab40-A21G), 35% (Ab40), and
40% (Ab42-A21G) excluding the ﬁrst 5-ns and considering
residues 1–8 disordered. Circular dichroism and NMR being
averaging techniques, it is not possible to determine whether
the b-signal originates from all Ab species or whether some
dimeric conformations with high (but not the highest) pop-
ulation exist with a richer b-composition. In addition, we
cannot exclude the possibility that the simulations have not
reached equilibrium yet. The second reason is that the effects
of the GROMOS force ﬁeld on the dynamics should be
conﬁrmed using other physically based force ﬁelds. The two
main ﬁndings of this study can be summarized as follows.
Firstly, Ab dimers are found in equilibrium between a
wide range of topologies, ranging from four-stranded to
seven-stranded b-sheets, with the strands S2 very mobile and
the location of the strands S1 ﬂuctuating between residues
11–20 (in Ab40) and residues 13–16 (in Ab40-A21G). This
ﬁnding raises the question whether an unique inhibitor can
block propagation of these structurally distinct dimers into
protoﬁbrils.
Secondly, the effect of A21G mutation on Ab dimers is
length-dependent and the structures and dynamics of Ab42-
A21G cannot be extrapolated from those of Ab40-A21G, and
vice versa. This is consistent with earlier experimental
studies suggesting that substitutions at positions 22 and 23
produce different effects on Ab assembly depending on
whether they occur in Ab40 or Ab42 (56). Speciﬁcally, we
ﬁnd that the mutation A21G impacts Ab dimers in three
ways. A21G destabilizes the b-sheets and notably strands S2
in Ab40, but not in Ab42. A21G also increases, to a higher
extent, the ﬂexibility of the central hydrophobic cluster
spanning residues 17–21 in Ab40 than in Ab42, and affects,
to various degrees, the populations of the intramolecular and
intermolecular salt bridges involving Glu22, Asp23, and Lys28
in Ab40 and Ab42. These three factors likely slow down the
formation of higher-order species to direct further assembly
into protoﬁbril and could explain the reduced aggregation rate
of Ab ﬁbrils containing the Flemish disease-causing mutation.
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